Fort Washington Investment Advisors Inc. OH Has $155.56 Million Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Fort Washington Investment Advisors Inc. OH trimmed its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 1.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 518,274 shares of the company’s stock after selling 10,070 shares during the quarter. HCA Healthcare accounts for 0.9% of Fort Washington Investment Advisors Inc. OH’s portfolio, making the stock its 26th largest holding. Fort Washington Investment Advisors Inc. OH owned approximately 0.20% of HCA Healthcare worth $155,560,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of HCA. FMR LLC grew its holdings in shares of HCA Healthcare by 322.3% in the 3rd quarter. FMR LLC now owns 3,141,769 shares of the company’s stock worth $1,276,909,000 after purchasing an additional 2,397,883 shares during the last quarter. Franklin Resources Inc. increased its holdings in shares of HCA Healthcare by 11.7% during the third quarter. Franklin Resources Inc. now owns 1,669,721 shares of the company’s stock worth $660,842,000 after buying an additional 174,946 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in HCA Healthcare by 2.8% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,487,367 shares of the company’s stock worth $604,511,000 after acquiring an additional 41,190 shares during the last quarter. Janus Henderson Group PLC raised its position in HCA Healthcare by 12.0% in the 3rd quarter. Janus Henderson Group PLC now owns 1,339,638 shares of the company’s stock valued at $544,467,000 after purchasing an additional 143,995 shares during the last quarter. Finally, Darsana Capital Partners LP increased its stake in shares of HCA Healthcare by 53.3% in the second quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock valued at $369,472,000 after buying an additional 400,000 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the sale, the insider now owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. This trade represents a 29.76 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, SVP Phillip G. Billington sold 3,897 shares of HCA Healthcare stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the transaction, the senior vice president now owns 52,702 shares in the company, valued at approximately $18,445,700. This represents a 6.89 % decrease in their position. The disclosure for this sale can be found here. 1.70% of the stock is owned by company insiders.

HCA Healthcare Price Performance

Shares of NYSE HCA opened at $318.47 on Wednesday. The business has a 50-day moving average of $315.74 and a 200-day moving average of $353.08. HCA Healthcare, Inc. has a fifty-two week low of $278.68 and a fifty-two week high of $417.14. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. The stock has a market capitalization of $80.67 billion, a price-to-earnings ratio of 14.30, a PEG ratio of 1.06 and a beta of 1.64.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 27th. Stockholders of record on Friday, December 13th were given a $0.66 dividend. The ex-dividend date of this dividend was Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.83%. HCA Healthcare’s payout ratio is 11.85%.

Analysts Set New Price Targets

A number of equities analysts have weighed in on HCA shares. TD Cowen dropped their target price on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a research note on Monday, October 28th. StockNews.com cut HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, November 4th. Raymond James cut HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. Wells Fargo & Company lowered shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and reduced their target price for the company from $400.00 to $320.00 in a research note on Monday, November 25th. Finally, JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $380.00 price objective on shares of HCA Healthcare in a research note on Tuesday, December 17th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have given a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus price target of $385.27.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.